Feed Insights Top Reports Pricing

⌘K

09:11:25·1641d

SECFilingvia Quantisnow

SEC Form 10-Q filed by Catalent, Inc.

ByQuantisnow·Wall Street's wire, on your screen.

CTLT· Catalent Inc.

Health Care

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTLT (Catalent Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

CTLT
Catalent Inc.
Health Care

Recent analyst ratings

Nov 16UpdateRobert W. Baird$53.00
Sep 5UpdateArgus$62.00
Jul 20UpdateWells Fargo$43.00
Jul 5UpdateJP Morgan$45.00
Jun 14UpdateJefferies$44.00
May 22UpdateJP Morgan$45.00

Related

PR435d
Catalent Announces New Board Appointments
SEC487d
SEC Form 15-12G filed by Catalent Inc.
PR499d
Lennox International Set to Join S&P 500 and BILL Holdings to Join S&P MidCap 400
INSIDER499d
Group Pres. Pharma & Consumer Gennadios Aristippos returned 135,286 shares to the company and was granted 21,562 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER499d
Group President, Biologics Mcerlane David returned 47,730 shares to the company and was granted 11,426 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER499d
Chief Accounting Officer Hatzfeld Michael returned 16,676 shares to the company and was granted 3,144 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER499d
SVP, Quality & Reg. Affairs Gunther Scott returned 52,573 shares to the company and was granted 12,938 shares, closing all direct ownership in the company (SEC Form 4)
INSIDER499d
SVP, General Counsel, CCO Ferraro Joseph Anthony was granted 14,265 shares and returned 38,232 shares to the company, closing all direct ownership in the company (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022